Electra Therapeutics sold 23,333,334 shares at $15.00 in its initial public offering. The final prospectus repeats the auditor's going concern paragraph from the registration statement.
Electra Therapeutics filed a Form S-1 on August 28, 2026, and the cover leaves the share count and price range blank. Its auditor's report includes a going concern paragraph, and the company says its cash may not cover the next 12 months.
Questions about Electra Therapeutics
Has Electra Therapeutics issued a going-concern warning?
Our latest story on this, dated Sep 18, 2026: "Electra Therapeutics prices IPO of 23,333,334 shares at $15.00, about $350 million". The story links the filing or release it is based on. Read the story.
When did Electra Therapeutics go public?
Our latest story on this, dated Sep 18, 2026: "Electra Therapeutics prices IPO of 23,333,334 shares at $15.00, about $350 million". The story links the filing or release it is based on. Read the story.
Has Electra Therapeutics raised money recently?
Our latest story on this, dated Sep 18, 2026: "Electra Therapeutics prices IPO of 23,333,334 shares at $15.00, about $350 million". The story links the filing or release it is based on. Read the story.
What is the ticker symbol of Electra Therapeutics?
Electra Therapeutics, Inc. trades under the ticker ETRA on NASDAQ.
Where is Electra Therapeutics listed?
Electra Therapeutics, Inc. is listed on NASDAQ.
What is the SEC CIK of Electra Therapeutics?
The SEC Central Index Key (CIK) for Electra Therapeutics, Inc. is 2088082. Its filings are on SEC EDGAR.
Which country or territory is Electra Therapeutics listed under?
Our directory records Electra Therapeutics, Inc. under United States.
What does Electra Therapeutics do?
Our directory classifies Electra Therapeutics, Inc. as: Pharmaceuticals: Major. This is a directory classification, not a description of the pipeline.
What is the ISIN of Electra Therapeutics?
The ISIN recorded for Electra Therapeutics, Inc. is US2848251060.
Does aibio.space cover Electra Therapeutics?
aibio.space lists Electra Therapeutics, Inc. among 2,820 public biotech companies and publishes its news here as stories appear.
Where is Electra Therapeutics incorporated?
SEC records list its state or country of incorporation as DE.
What is the latest Electra Therapeutics (ETRA) stock news?
Our latest story on Electra Therapeutics, dated Sep 18, 2026: "Electra Therapeutics prices IPO of 23,333,334 shares at $15.00, about $350 million". Electra Therapeutics sold 23,333,334 shares at $15.00 in its initial public offering. The final prospectus repeats the auditor's going concern paragraph from the registration statement. Source.
How long will Electra Therapeutics's cash last?
From our story of Sep 18, 2026: The final prospectus repeats the auditor's going concern paragraph from the registration statement. Source.
How much cash does Electra Therapeutics have?
From our story of Sep 18, 2026: For the six months ended June 30, 2026, the company reported a net loss of $48.9 million, and it used $38.9 million of cash in operating activities. Source.
Is Electra Therapeutics a smaller reporting company?
SEC records list Electra Therapeutics, Inc.'s filer category as: <br>Emerging growth company.
Investor discussion: Electra Therapeutics
Members talk about Electra Therapeutics (ETRA). Reader posts, not aibio.space reporting, and not investment advice.
Rules
Securities violations are strictly forbidden. No market manipulation, no pump-and-dump, no false or misleading statements, and no inside information.
Say whether you hold the stock. Every post states long, short or no position.
No paid or sponsored posts. Do not post for anyone who pays or rewards you.
No buy or sell calls and no price targets.
No accusations of crime or fraud against named people unless you link a court filing or a regulator's release that makes them.
No personal details and no spam. No links at all for your first 7 days as a member.
Posts that break the rules may be deleted without notice, and the account restricted or closed. See the terms and the privacy policy.
Capital-markets timeline
Financings, listing notices, splits, legal actions and other investor events at Electra Therapeutics, newest first. Each line links the filing it comes from.
Filed a registration statement for a share offering. SEC Form S-1. Source
Stock chart
Price chart and quote supplied by TradingView, delayed as the exchange requires. It loads only if you choose to show it. Information only, not investment advice. Open NASDAQ:ETRA on TradingView.
SEC filings and registration
SEC name
Electra Therapeutics, Inc.
CIK
2088082
Industry (SIC)
Biological Products, (No Diagnostic Substances) (2836)
US tickers
ETRA (Nasdaq)
State or country of incorporation
DE
Fiscal year ends
December 31
Filer category
<br>Emerging growth company
Business address
230 EAST GRAND AVENUE, SUITE S-100, SOUTH SAN FRANCISCO, CA, 94080
Phone
(888) 743-2290
Recent filings (8-K and 6-K are the company's own announcements)
Source: SEC EDGAR, retrieved October 23, 2026. Shares outstanding is the cover-page figure from the latest periodic report. The SEC does not publish share prices.
Listing details
Electra Therapeutics, Inc. is a public biotech or pharmaceutical company listed on NASDAQ under the ticker ETRA, recorded under United States. The directory classifies it as Pharmaceuticals: Major. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them.
Listing facts come from our company directory, researched on October 22, 2026. A listing record does not certify that a security currently trades. Tell us about a change. Work at this company? Claim this page.
Published and maintained by aibio.space. Not investment advice. How we work.
Who manages this pageThis page is managed by aibio.space. The company does not run, edit or pay for this page. News, desk views and Investor Ranks are written and managed independently by aibio.space under our editorial and analytical judgment. Opinion only, not investment advice. How we work · Terms · Request a correction
aibio